MedTrace Logo

ACTiF- Assessment of Closed Tibial Fractures

NCT00533377 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 276

Last updated 2012-02-17

No results posted yet for this study

Summary

The purpose of this study is to find out the good and bad effects of an investigational drug called CP-533,536 in patients with closed fracture of the tibial shaft undergoing internal fixation using reamed inter-locked IM nailing procedure

Conditions

  • Tibial Fractures

Interventions

DRUG

CP-533, 536

Active study drug

DRUG

Placebo

Placebo vehicle

PROCEDURE

Standard of Care

Standard surgical procedure

DRUG

CP-533,536

Active study drug

DRUG

CP-533,536

Active study drug

DRUG

CP-533,536

Active study drug

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • United States
  • Australia
  • Bosnia and Herzegovina
  • Canada
  • Croatia
  • India
  • Japan
  • Russia
  • South Africa
  • Spain
  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00533377 on ClinicalTrials.gov